Replies to post #479396 on NorthWest Biotherapeutics Inc (NWBO)

[BigAl2020]

All this is supplementary information of course because there is not an official endpoint in the trial for this.

Aren’t there some secondary endpoints that have not been disclosed at this point?

[sentiment_stocks]

Yes, Chiugray… your explanation mirrors my understanding as well. An incredibly interesting approach, that would definitely add dimension to the study results. I’d be very interested in seeing this type of analysis.

[biosectinvestor]

each patient being their own control is definitely intriguing

Crossover trials do have some other aspects to them. Definitely intriguing.